Scopus
YÖKSİS DOI Eşleşti
SJR Q1
Long-Term Outcomes of Chenodeoxycholic Acid Therapy for Cerebrotendinous Xanthomatosis: A Nationwide Study on Prognostic Factors and Treatment Response
Journal of Inherited Metabolic Disease · Temmuz 2025
YÖKSİS Kayıtları
Long-Term Outcomes of Chenodeoxycholic Acid Therapy for Cerebrotendinous Xanthomatosis: A Nationwide Study on Prognostic Factors and Treatment Response
Journal of Inherited Metabolic Disease · 2025 SCI-Expanded
Prof. Dr. HALUK GÜMÜŞ →
Makale Bilgileri
Scimago Dergi (ISSN Eşleşmesi)
Journal of Inherited Metabolic Disease
Q1
OA
SJR Skoru1,401
H-Index131
YayıncıSpringer Netherlands
ÜlkeNetherlands
Genetics (Q1)
Genetics (clinical) (Q1)
Metrikler
4
Atıf